We are live on
!
Find out more
T
TOBAM Portfolio holdings
AUM
$384M
1-Year Est. Return
10.32%
This Fund
S&P 500
This Quarter
Est. Return
+10.73%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.12B
AUM Growth
-$27.7M
(-2.4%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-10.8%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
403
New
29
Increased
120
Reduced
176
Closed
26
Top Buys
| 1 |
Progressive
PGR
|
+$10.1M |
| 2 |
Humana
HUM
|
+$9.03M |
| 3 |
Archer Daniels Midland
ADM
|
+$7.99M |
| 4 |
Toro Company
TTC
|
+$7.78M |
| 5 |
Intel
INTC
|
+$7.36M |
Top Sells
| 1 |
Super Micro Computer
SMCI
|
+$24.5M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
+$15.2M |
| 3 |
Merck
MRK
|
+$12.3M |
| 4 |
Eli Lilly
LLY
|
+$9.47M |
| 5 |
Las Vegas Sands
LVS
|
+$9.43M |
Sector Composition
| 1 | Healthcare | 32.63% |
| 2 | Consumer Staples | 23.65% |
| 3 | Financials | 11.73% |
| 4 | Technology | 9.93% |
| 5 | Communication Services | 8.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$1.04T
| $33.9M | 3.04% |
43,604
-13,302
| -23% | -$9.47M |
|
2
General Mills
GIS
$20.7B
| $32.9M | 2.95% |
470,725
-24,876
| -5% | -$1.62M |
|
3
AbbVie
ABBV
$449B
| $31.9M | 2.86% |
175,361
-43,386
| -20% | -$7.48M |
|
4
Church & Dwight Co
CHD
$23.5B
| $30.9M | 2.77% |
296,417
-6,566
| -2% | -$657K |
|
5
McKesson
MCK
$98.5B
| $30.6M | 2.75% |
57,063
-5,261
| -8% | -$2.67M |
|
|
6
Progressive
PGR
$120B
| $30M | 2.69% |
145,248
+54,354
| +60% | +$10.1M |
|
7
Clorox
CLX
$11.9B
| $29.8M | 2.67% |
194,540
-26,793
| -12% | -$4M |
|
8
Cboe Global Markets
CBOE
$29.1B
| $29.6M | 2.65% |
161,122
+39,540
| +33% | +$7.3M |
|
|
9
Humana
HUM
$46.4B
| $29.5M | 2.64% |
84,942
+23,819
| +39% | +$9.03M |
|
10
AT&T
T
$153B
| $29.1M | 2.61% |
1,653,323
-45,999
| -3% | -$785K |
|
11
J.M. Smucker
SJM
$12.2B
| $28.2M | 2.53% |
224,000
-24,636
| -10% | -$3.12M |
|
|
12
Merck
MRK
$315B
| $27.5M | 2.46% |
208,346
-99,582
| -32% | -$12.3M |
|
13
Kroger
KR
$35.9B
| $27.5M | 2.46% |
480,565
-94,848
| -16% | -$4.67M |
|
14
Newmont
NEM
$97B
| $25.9M | 2.32% |
721,794
+18,781
| +3% | +$647K |
|
15
Pfizer
PFE
$143B
| $25.2M | 2.26% |
908,042
+18,715
| +2% | +$519K |
|
|
K
16
DELISTED
Kellanova
K
| $25.1M | 2.25% |
437,482
-144,240
| -25% | -$7.94M |
|
17
United Therapeutics
UTHR
$22.5B
| $25M | 2.24% |
108,647
-5,110
| -4% | -$1.15M |
|
18
Neurocrine Biosciences
NBIX
$17.2B
| $24.6M | 2.2% |
178,253
-48,588
| -21% | -$6.64M |
|
19
Johnson & Johnson
JNJ
$602B
| $24.1M | 2.16% |
152,093
-53,495
| -26% | -$8.51M |
|
20
Verizon
VZ
$183B
| $22.9M | 2.05% |
545,873
+7,920
| +1% | +$319K |
|
21
SLB Ltd
SLB
$70.4B
| $21.1M | 1.89% |
384,288
-16,993
| -4% | -$857K |
|
22
Arista Networks
ANET
$212B
| $20.8M | 1.86% |
286,656
-66,476
| -19% | -$4.48M |
|
23
Campbell Soup
CPB
$6.75B
| $20.2M | 1.81% |
454,302
-82,788
| -15% | -$3.58M |
|
24
Bristol-Myers Squibb
BMY
$124B
| $19.6M | 1.76% |
361,720
-170,184
| -32% | -$8.67M |
|
25
DaVita
DVA
$15B
| $16.1M | 1.44% |
116,735
-19,488
| -14% | -$2.34M |
|
Similar funds
PCM
DFA
BAMG
DR
GCP
DC
GA
VI